Company Filing History:
Years Active: 2021-2025
Title: The Innovative Mind of Marie Woolley-Roberts
Introduction
Marie Woolley-Roberts, an accomplished inventor from Cambridge, GB, has made significant contributions to the field of cannabinoid research. With a remarkable portfolio of seven patents, her work primarily focuses on the therapeutic applications of cannabinoids in treating various disorders.
Latest Patents
One of her latest inventions is centered around the use of cannabidiolic acid (CBDA) in the treatment of autism spectrum disorder (ASD) and associated conditions such as Fragile X syndrome, Rett syndrome, and Angelman syndrome. The invention demonstrates that CBDA can aid in improving cognitive dysfunction in rodent models of these disorders. Moreover, she emphasizes the importance of a highly purified extract, where CBDA accounts for more than 95% of the total extract, and explores synthetically produced alternatives.
Another significant patent encompasses her findings on cannabidiol (CBD), a naturally occurring cannabinoid in the cannabis plant. Contrary to prior methods, she highlights that certain botanical CBD preparations are more effective than fully synthetic counterparts. This realization opens new avenues for the enhanced treatment of various diseases and emphasizes the importance of maintaining specific chemical components in these preparations for optimal efficacy.
Career Highlights
Marie Woolley-Roberts is affiliated with GW Research Limited, a company known for its dedication to cannabis-based research and development. Her innovative spirit and dedication to advancing cannabinoid research position her as a prominent figure in this evolving field.
Collaborations
Throughout her career, Marie has collaborated with notable colleagues such as Geoffrey W. Guy and James Brodie, who share her passion for enhancing our understanding of cannabinoids and their therapeutic potential.
Conclusion
Marie Woolley-Roberts continues to push the boundaries of cannabinoid research through her inventions and patents. Her work not only contributes to the scientific community's understanding of autism spectrum disorders and other conditions but also sets the stage for potential breakthroughs in the medical treatment landscape. As she forges ahead in her innovative journey, the implications of her research promise to improve the lives of many individuals affected by these disorders.